Effect of topical calcipotriene/betamethasone (Taclonex) in managing localized mild breakthrough in moderate to severe plaque psoriasis patients receiving efalizumab (Raptiva).
Phase of Trial: Phase IV
Latest Information Update: 02 Apr 2012
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 02 Apr 2012 Planned end date (1 Feb 2009) added as reported by ClinicalTrials.gov: US record.
- 07 Oct 2009 New trial record.